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Abstract:
Heart failure due to metabolic derangements is not common in clinical practice. However,
outcome is usually positive given that the precipitating factor is recognized and treatment is
initiated in a timely fashion. We report an unusual case of reduced left ventricular systolic
function in the setting of hypocalcemia in a patient without known structural heart disease. Delay
in seeking appropriate medical attention has culminated in cardiac dysfunction that was
favorably altered with correction of hypocalcemia.
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Introduction:
Most patients with cardiomyopathy have a poor prognosis due to progressive and irreversible
myocardial dysfunction. Although some causes of cardiomyopathy are well known, such as toxic
substances or viral infections, rarely, is there a reversible cause identified and the etiology is
deemed idiopathic. The role of calcium in myocardial excitation contraction coupling has been
well described but hypocalcemic cardiomyopathy due to hypoparathyroidism is an infrequently
encountered condition. It is usually refractory to conventional treatment but responds favorably
to restoration of normocalcemia. (1)
Cardiac dysfunction secondary to metabolic derangements should be considered in the
differential diagnosis of heart failure in previously healthy patients who do not respond
adequately to the usual treatment. Prompt recognition of the provoking factor is important since
the disease process is potentially reversible. We report a case and discuss the mechanism of acute
cardiomyopathy associated with hypocalcemia.
Case Report:
A 57 year old previously healthy white woman was found at home by her daughter having
convulsions. A CT-scan of the head at a local emergency department (ED) was obtained with
normal results. She was transferred to our center because of elevated cardiac enzymes.
Subsequently she regained consciousness, reporting chest pain that was relieved by short acting
nitroglycerin. She denied shortness of breath but reported dry cough and fatigue. The patient
appeared distressed but was alert and oriented. Her blood pressure (BP) was 98/47 mmHg, heart
rate regular 97 beats per minute, respiratory rate 28 per minute, temperature 96°F and oxygen
saturation 92% on 4 liters of oxygen by nasal canula. Physical examination showed faint S1 and
S2 without murmur; bilateral fine crepitations in all lung fields, and pitting lower limb edema.
Chvostek's and Trousseau's sign (carpopedal spasm) were not elicited. The patient’s past medical
history was insignificant; no history of neck surgery or radiation as a reason for hypothyroidism
or hypoparathyroidism, there was no history of alcohol abuse that may result in systolic
dysfunction. Furthermore, tachycardia mediated cardiomyopathy was ruled out since there was
no history of arrhythmia and none was identified during her hospital stay while she was on
telemetry monitoring. Iron study performed to screen for hemochromatosis is within normal.
There was no known family history of endocrine disorders.

Initial workup in the ED revealed a calcium level of 5mg/dl (refer to Table 1 for laboratory
results). A 12 lead electrocardiogram (EKG) (Figure 1) demonstrated T-wave inversion along
with a prolonged QT interval (QTc= 0.693 sec using Bazett’s formula). Urine drug screen
including cocaine was negative.
Table 1: Laboratory results
Laboratory
Calcium
Ionized calcium
Phosphorus
Magnesium
Parathyroid hormone
25, Hydroxy vitamin D
TSH
Free T4
Troponin
Total CK
CKMB
Myoglobin
Creatinine
BUN

Value
5 mg/dl
0.65 mmol/l
8.2 mg/dl
1.7 mg/dl
2.5 pg/ml
8 ng/ml
21.48 miliU/L
0.62 ng/dl
9.3
13983
77.1
>1000
1.6 mg/dl
19mg/dl

Range
8.5-10.5 mg/dl
1.12-1.38 mmol/l
2.5-4.5 mg/dl
1.6-2.4 mg/dl
(8-97 pg/ml)
(32-100ng/ml)
0.370-4.420 miliU/L
0.75-2
0.0-0.5
55-170
0.0-5
0-110
0.7-1.4
7-21 mg/dl

Figure 1: Electrocardiogram demonstrating prolonged corrected QT interval (QTc= 0.693
second using Bazett’s formula) and T-wave inversion in leads I and AVL.

Her chest X-ray showed pulmonary edema (Figure 2). Echocardiogram demonstrated a globally
hypokinetic left ventricle with severely depressed left ventricular ejection fraction of 25-30%
without evidence of left ventricular hypertrophy or significant valvular lesions. Subsequent
cardiac catheterization revealed no angiographic evidence of obstructive coronary artery disease.

Figure 2: Chest X-ray demonstrating bilateral interstitial infiltrate consistent with
pulmonary edema.
The patient initially received a single dose of intravenous calcium gluconate of 1000 milligrams
given slowly to reverse the acute effects of hypocalcemia including seizures. The levels of
ionized calcium were closely followed and a dose of calcium chloride 1000 milligrams was
subsequently administered via central line resulting in the correction of serum calcium. The
patient’s symptoms started to subside, hemodynamic status improved and EKG changes resolved
after serum calcium was normalized (Figure 3). Endocrinology service was consulted to provide
advice on treating hypothyroidism and hypoparathyroidism. The patient was started on oral
supplementation of calcium carbonate and vitamin D (1,25-dihydroxycholecalciferol) and was
also started on thyroid replacement therapy. She remained asymptomatic and was discharged
home in a stable condition. Unfortunately, the patient was lost to cardiology follow-up, and her
long-term clinical course is unknown.

Figure 3: Electrocardiogram demonstrating normalization of corrected QT interval (QTc= 0.41
second using Bazett’s formula) and resolution of previously noted T wave inversion.
Discussion:
This unique case demonstrates acute cardiomyopathy precipitated by metabolic derangement in
the absence of other obvious etiologies.

It is well established that calcium ions play a central role in myocardial excitation contraction
coupling (Figure 4) and myocardial relaxation. (2) Once the intracellular concentration of
calcium increases, calcium ions bind to the protein troponin which initiates contraction by
allowing the contractile proteins, myosin and actin, to associate through cross-bridge formation.
An inward flux of extracellular calcium ions through L-type calcium channels a voltage
dependent calcium channel, sustains the depolarization of cardiac muscle cells for a longer
duration. (2) Therefore, hypocalcemia may cause cardiac dysfunction that usually does not
respond to positive inotropic and diuretic therapies. While moderate reduction of serum calcium
for a limited period of time may not result in a clinically appreciable decrease in myocardial
function, it appears that profound and prolonged hypocalcemia may result in secondary
cardiomyopathy manifested clinically by congestive heart failure that is responsive only to
normalization of serum calcium. (3) Several cases have been reported in medical literature
demonstrating the restoration of cardiac function after correction of serum calcium levels (Table
2).

Figure 4: The role of calcium in systole and diastole at cellular level. 1) Calcium enters via Ltype calcium channels following depolarization. 2) Entering calcium stimulates the
release of calcium via Ryanodine receptors on sarcoplasmic reticulum. 3) Calcium
interacts with Troponin C initiating contraction (systole). 4) Calcium uptake via
SERCA results in relaxation (diastole). 5) Calcium is extruded outside myocyte via
Na+/Ca2+ exchanger (17, 18).

Table 2: Case reports of hypocalcemic cardiomyopathy illustrating the impact of hypoclacemia
on cardiac function and the improvement in systolic and/or diastolic function with
normocalcemia.
Author Patient’s
Clinical
Calcium
EF
Diagnosis
Response
age
Presentation
level
(years)
(mg/dl)
Ozerka
40
CHF,
6.3
25%
Primary
LVEF
n et al.
NHYA class
hypoparathyroidism improved
(9)
III
Lam et
37
CHF
2.9
Systolic
Iatrogenic
Persistence
al. (10)
and
hyoparathyroidism of systolic
diastolic
and
dysfuncdiastolic
tion
dysfunction
Behagh
76
CHF
4.8
36%
Iatrogenic
Normalizael et al
hypoparathyroidism
tion of
(11)
systolic
function
after 2
months
Sung et
57
CHF,
5.16
37%
Iatrogenic
EF
al. (12)
NHYA class
hypoparathyroidism improved
III
to 61%
Ari H
27
CHF
2.9
20-25% Vitamin D resistant
EF
et al.
rickets
improved
(13)
to 55%
Avsar
40
CHF
3.5
25%
Iatrogenic
EF
et al.
hypoparathyroidism improved
(14)
to normal
Kini et
30
CHF
3.03
20%
Primary
Clinically
al. (15)
hypoparathyroidism improved
but EF at
35% after
40 months
Fisher
38
Atypical
6.8
37%
Iatrogenic
Normalizaet al
chest pain,
hypoparathyroidism
tion of
(16)
ischemic
LVEF after
EKG
3 months
changes

Our patient had EKG changes that were resolved after correction of the serum calcium. The EKG
changes could be explained by coronary artery spasm, known to occur with hypomagnesemia,
which in turn is often associated with hypocalcemia. (4)

The deficiency of thyroid hormones can be also connected with a range of metabolic and
hemodynamic changes that can contribute to the genesis of heart failure. The major
cardiovascular changes that occur in hypothyroidism include decreased cardiac contractility,
reduced heart rate, and increased peripheral vascular resistance. (5, 6)
The history and laboratory findings in this patient suggest that hypocalcemia, secondary to
hypoparathyroidism, in the presence of unrecognized and untreated hypothyroidism have
predisposed to acute decompensation of heart failure. Attributing acute myocardial dysfunction
to hypocalcemia in this case is justified by several explanations. First, the patient demonstrated
rapid clinical improvement upon administration of calcium without the use of inotropic agents or
diuretics. Second, supplementation with thyroid replacement therapy does not usually result in
prompt reversal of metabolic events. Third, although the most common reason for impaired
cardiac function is ischemic heart disease, the presence of normal coronary angiogram excluded
significant atherosclerosis as the underlying cause. Fourth, there was an absence of usual
etiologies of systolic dysfunction including alcoholism, long standing tachycardia, cocaine abuse
and structural heart disease.
Symptomatic patients presenting with neuromuscular irritability secondary to hypocalcaemia or
asymptomatic patients with corrected serum calcium of less than 7.5 mg/dl are treated with
intravenous calcium gluconate. (7) Calcium gluconate (10 ml of 10%) can be slowly infused
over 10-20 minutes. (7) It is preferred over calcium chloride which may cause local irritation.
Calcium showed not to be infused rapidly due to risk of dysarrhythmias and cardiac arrest. (8)
Infusion of calcium can be repeated until symptoms have resolved. Oral calcium replacement
should be given concurrently and a vitamin D analogue added if parathyroid hormone is deficient
(7) as in this case.
Conclusion:
Hypocalcemia secondary to hypoparathyroidism is a rare cause of heart failure in adults, and is
curable after administration of calcium. It is can be overlooked, although easily diagnosed and
treated.
It is important to consider metabolic derangement in patients with symptoms of heart failure of
unidentified cause, as it is potentially reversible.
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